BioWorld Science

Aug. 13, 2021

View Archived Issues

Equillium presents additional data from EQUALISE study of itolizumab

Read More

ON-108600 leads to potent tumor growth inhibition in chemotherapy-resistant TNBC models

Read More

Phase Ib/II data reported from CARTITUDE-1 study of ciltacabtagene autoleucel

Read More

Preclinical data confirm survival benefit of adding Veyonda to LuPSMA in prostate cancer

Read More

lncRNA HULC linked to phenylketonuria prevention, HULC-mimetics show therapeutic promise

Read More

B-Raf, MEK1 inhibitors discovered at Chugai

Read More

Shenzhen Salubris Pharmaceuticals presents new cathepsin K inhibitors

Read More

Shanghai Hengrui Pharmaceutical and others patent ADCs with eribulin derivatives

Read More

SSAO inhibitors identified at Shanghai Ennova Biopharmaceutical, Ennovabio Pharmaceuticals

Read More

VYNE and In4Derm enter licence agreement for discovery and development of BET inhibitor platform

Read More

FDA clears IND application for first-in-human trial of IO-108

Read More

Mustang Bio and Mayo Clinic collaborate on development of novel CAR T technology

Read More

Sen-Jam and Duke-NUS Medical School partner to develop novel COVID-19 therapy

Read More

Cogent initiates phase II study of CGT-9486 in systemic mastocytosis

Read More

Nimbus and Schrödinger extend drug discovery collaboration

Read More

Moderna initiates phase I/II study of mRNA-3705 in methylmalonic acidemia

Read More

Phase I/II study of ChulaCov19 vaccine initiates at Chulalongkorn University

Read More

SARS-CoV-2 spike ectodomain protein StriFK vaccine with adjuvant reduces transmission in animals

Read More